American Century Companies Inc Adc Therapeutics Sa Transaction History

American Century Companies Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.66 - $10.31 $885 - $1,958	-190 Reduced 0.04%	451,637 $2.18 Million
Q2 2022 Aug 12, 2022	BUY	$5.96 - $14.99 $181,958 - $457,644	30,530 Added 7.25%	451,827 $3.59 Million
Q1 2022 May 11, 2022	BUY	$13.28 - $20.03 $1,633 - $2,463	123 Added 0.03%	421,297 $6.19 Million
Q4 2021 Feb 07, 2022	BUY	$19.29 - $31.51 $799,107 - $1.31 Million	41,426 Added 10.91%	421,174 $8.51 Million
Q3 2021 Nov 10, 2021	SELL	$20.45 - $30.0 $6,155 - $9,030	-301 Reduced 0.08%	379,748 $10.3 Million
Q2 2021 Aug 05, 2021	BUY	$20.38 - $27.04 $18,586 - $24,660	912 Added 0.24%	380,049 $9.25 Million
Q1 2021 May 14, 2021	BUY	$22.75 - $34.05 $888,342 - $1.33 Million	39,048 Added 11.48%	379,137 $9.26 Million
Q4 2020 Feb 12, 2021	BUY	$25.26 - $38.02 $1.89 Million - $2.85 Million	74,951 Added 28.27%	340,089 $10.9 Million
Q3 2020 Nov 13, 2020	BUY	$32.87 - $51.05 $8.72 Million - $13.5 Million	265,138 New	265,138 $8.75 Million

55.1M

82.7K

31.5K

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $135M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

Stay updated on American Century Companies Inc with notifications on news.